Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Multimedia
Events
About Us
MDMA
Lykos Therapeutics Slashes Workforce, Reshuffles Leadership After FDA Rejection
August
22
,
2024
MDMA for PTSD: Setback Sparks New Battle Plan
August
14
,
2024
Fluence, Enthea Partner to Expand Access for Ketamine-Assisted Therapy
July
7
,
2024
Analysis: MDMA Setback Shows Psychedelic Medicine Still Has Work Ahead
June
7
,
2024
Optimi Health Receives Regulatory Approval to Export to Australia
June
3
,
2024
Lykos Appoints Finance Veteran Scott Giacobello to Board of Directors
May
31
,
2024
‹
1
2
3
4
›
»
